4.6 Article

Neuron-Specific Enolase (NSE) as a Biomarker for Autistic Spectrum Disease (ASD)

Related references

Note: Only part of the references are listed.
Review Genetics & Heredity

Therapeutic modulation of JAK-STAT, mTOR, and PPAR-γ signaling in neurological dysfunctions

Sumit Kumar et al.

Summary: The JAK-STAT, mTOR, and PPAR gamma signaling pathways play important roles in neuronal activity and brain development, and their overactivation or inhibition can lead to neurocomplications. Even minor disruptions in cellular and molecular processes can have significant consequences as neurological and neuropsychiatric diseases. Therefore, modulators of these signaling pathways may serve as potential therapeutic targets for preventing neuronal dysfunctions.

JOURNAL OF MOLECULAR MEDICINE-JMM (2023)

Review Psychiatry

Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review

Samuele Cortese et al.

Summary: Neurodevelopmental disorders such as ADHD, autism spectrum disorder, and intellectual disability can be identified early in development. However, there is a lack of valid and reliable biomarkers for the timely diagnosis of these disorders. A systematic review of studies on candidate diagnostic biomarkers for these disorders in children and adolescents found that none of the biomarkers met the criteria of specificity and sensitivity of at least 80% in two or more independent studies. Future research should focus on multivariable and multi-level approaches to identify valid candidate biomarkers.

WORLD PSYCHIATRY (2023)

Article Psychiatry

Excitatory/inhibitory imbalance in autism: the role of glutamate and GABA gene-sets in symptoms and cortical brain structure

Viola Hollestein et al.

Summary: The E/I imbalance hypothesis suggests that the imbalance between excitatory and inhibitory mechanisms underlies the behavioral characteristics of autism. This study used innovative analysis methods to investigate the relationships between genetic variance, brain structure, and autism symptomatology. The results suggest complex relationships between E/I-related genetics and autism symptom profiles as well as brain structure alterations.

TRANSLATIONAL PSYCHIATRY (2023)

Article Medicine, General & Internal

Safety of Sirolimus in Patients with Tuberous Sclerosis Complex under Two Years of Age-A Bicenter Retrospective Study

Dominika Smialek et al.

Summary: This study is the first to determine and assess the severity of adverse effects of sirolimus administered to children under two years of age with TSC. The study found that adverse effects associated with sirolimus use were frequent yet not life- or health-threatening. Further multicenter prospective clinical trials should determine the long-term safety of sirolimus.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Biochemistry & Molecular Biology

Autism Spectrum Disorders: A Recent Update on Targeting Inflammatory Pathways with Natural Anti-Inflammatory Agents

Ramu Singh et al.

Summary: Autism spectrum disorder (ASD) is a heterogeneous category of developmental psychiatric disorders characterized by inadequate social interaction, less communication, and repetitive phenotype behavior. The reported prevalence differs across countries. Natural anti-inflammatory agents have been linked to inflammatory pathways associated with ASD. New strategies using natural anti-inflammatory medicines are being developed to treat ASD. This review summarizes the potential protective effects of natural anti-inflammatory agents on the developing brain during pregnancy and their role in translational research studies on ASD.

BIOMEDICINES (2023)

Article Cell Biology

Advantages of mesenchymal stem cell over the other stem cells

Janani Gopalarethinam et al.

Summary: Stem cells have the potential to convert into specific cell types and are used for regenerating damaged tissues. There are adult, embryonic, and induced pluripotent stem cells, each with its advantages and disadvantages. Mesenchymal stem cells, a type of adult stem cells, have a wide range of differentiation potential and can avoid immune rejection during transplantation. However, there are concerns regarding maldifferentiation, immunosuppression, and tumor growth associated with MSC therapy.

ACTA HISTOCHEMICA (2023)

Article Psychiatry

The Autism Biomarkers Consortium for Clinical Trials: Initial Evaluation of a Battery of Candidate EEG Biomarkers

Sara Jane Webb et al.

Summary: This study evaluated a battery of EEG assays as potential biomarkers for clinical trials in ASD, and found that resting state, faces task, and VEP showed promise in terms of data acquisition and construct performance. The study also observed that the faces task's P1 and N170 performed well in terms of group discrimination and phenotype correlations, providing valuable information for further evaluation of biomarkers.

AMERICAN JOURNAL OF PSYCHIATRY (2023)

Article Biochemistry & Molecular Biology

Characterization of De Novo Promoter Variants in Autism Spectrum Disorder with Massively Parallel Reporter Assays

Justin Koesterich et al.

Summary: Autism spectrum disorder (ASD) is influenced by both common and rare genetic variations, with disruptive rare variants in protein-coding regions having a clear impact on symptoms. However, the role of rare non-coding variants, including promoters, remains unclear. In this study, the functional impact of de novo mutations in promoter regions in ASD cases and controls was analyzed using massively parallel reporter assays. Although certain functionally high confidence de novo variants were identified, no differences in functional impact based on ASD diagnostic status were found.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Neuroinflammation and Oxidative Stress in the Pathogenesis of Autism Spectrum Disorder

Noriyoshi Usui et al.

Summary: Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by social communication impairments, repetitive behaviors, restricted interests, and sensory sensitivities, caused by genetic and/or environmental factors. Recent studies have suggested that inflammation and oxidative stress play a role in the pathogenesis of ASD. This review focuses on the role of maternal immune activation (MIA), a common environmental risk factor during pregnancy, in inducing inflammation and oxidative stress in the placenta and fetal brain, leading to neurodevelopmental impairments and behavioral symptoms in offspring. Additionally, the effects of anti-inflammatory drugs and antioxidants in both animal and clinical studies of ASD are discussed. The review provides new insights into the involvement of inflammation and oxidative stress in the pathogenesis of ASD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

mTOR Signaling Disruption and Its Association with the Development of Autism Spectrum Disorder

Shilu Deepa Thomas et al.

Summary: Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder characterized by impairments in social interaction and communication along with repetitive stereotypic behaviors. There are no specific biomarkers for diagnostic screening or treatments available for autistic patients. Genetic disorders such as tuberous sclerosis complex, phosphatase and tensin homolog, and fragile X syndrome are associated with high prevalence of ASD. Preclinical investigations in animal models have revealed irregularities in the PI3K/Akt/mTOR signaling pathway as well as ASD-related behavioral defects. Modulation of the pathway with plant bioactive molecules has shown beneficial evidence in ASD treatment.

MOLECULES (2023)

Article Neurosciences

Molecular and network-level mechanisms explaining individual differences in autism spectrum disorder

Amanda M. M. Buch et al.

Summary: Using a large neuroimaging dataset, this study identified three latent dimensions of functional brain network connectivity that predicted individual differences in autism spectrum disorder (ASD) behaviors. Four reproducible ASD subgroups were discovered with distinct functional connectivity alterations and clinical symptom profiles, which were validated in an independent sample. Integrating neuroimaging data with gene expression data revealed that ASD-related functional connectivity could be explained by regional differences in the expression of distinct ASD-related gene sets, implicating different molecular signaling pathways.

NATURE NEUROSCIENCE (2023)

Article Psychiatry

Interplay of Metabolome and Gut Microbiome in Individuals With Major Depressive Disorder vs Control Individuals

Najaf Amin et al.

Summary: Metabolomics provides a comprehensive approach to evaluating complex diseases, and this study identified metabolic signatures associated with major depressive disorder (MDD) and revealed the interplay between the gut microbiome and metabolome in lipid metabolism in individuals with MDD.

JAMA PSYCHIATRY (2023)

Review Genetics & Heredity

The Autism Spectrum: Behavioral, Psychiatric and Genetic Associations

Ann Genovese et al.

Summary: Autism spectrum disorder (ASD) is a group of genetic neurobehavioral disorders that affect social communication skills and behaviors. This review examines the behavioral, psychiatric, and genetic associations related to ASD, including the involvement of over 800 genes and several genetic syndromes. The etiology of ASD is influenced by a complex interplay between inheritance and environmental factors, with a heritability estimate between 70 and 90%. Genetic factors also impact clinical evaluations, diagnoses, and treatment options for individuals with ASD, including the use of pharmacogenetics testing to guide medication selection.

GENES (2023)

Article Pediatrics

Autism spectrum disorder diagnosis using a new panel of immune- and inflammatory-related serum biomarkers: A case-control multicenter study

Benjamin Gesundheit et al.

Summary: The aim of this study was to identify diagnostic biomarkers for autism spectrum disorder (ASD) that could distinguish between ASD and typically developing children. By analyzing blood samples from 102 children with ASD and 97 typically developing children, 12 biomarkers were identified that achieved an accuracy of 82% in diagnosing ASD with a threshold of 0.5. These biomarkers have the potential to serve as an objective assay for early and accurate diagnosis of ASD.

FRONTIERS IN PEDIATRICS (2023)

Review Psychiatry

In Search of Biomarkers to Guide Interventions in Autism Spectrum Disorder: A Systematic Review

Mara Parellada et al.

Summary: The aim of this study was to evaluate response biomarkers correlated with autism spectrum disorder (ASD) symptoms. A systematic review was conducted and 280 articles were included, reporting on 940 biomarkers. However, the studies showed high heterogeneity and there is currently no sufficient evidence for response biomarkers in ASD clinical trials.

AMERICAN JOURNAL OF PSYCHIATRY (2023)

Review Immunology

Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD)

H. K. Hughes et al.

Summary: Autism spectrum disorder (ASD) is a diverse neurodevelopmental disorder characterized by deficits in communication and social behavior, often accompanied by restricted and repetitive behaviors. The prevalence of ASD has been increasing in recent decades, and both genetic and environmental factors are believed to contribute to its etiology. This review explores the evidence of innate immune dysfunction in ASD, including abnormal cellular function, neuroinflammation, and microglial activation.

BRAIN BEHAVIOR AND IMMUNITY (2023)

Article Neurosciences

Correlation of mutated gene and signalling pathways in ASD

Madhavi Apte et al.

Summary: Autism is a complex spectrum of neurodevelopmental disorders characterized by repetitive and restricted behaviors and interests, as well as social interaction and communication difficulties that manifest in infancy. Over 18 million Indians, according to the National Health Portal of India, and 1 in 160 children worldwide, according to the WHO, are diagnosed with autism spectrum disorders. This review discusses the intricate genetic architecture underlying autism and summarizes the role of proteins likely to be involved in its development, along with the impact of genetic mutations on convergent signaling pathways and brain circuitry development, as well as the role of cognition development and theory of mind in autism and the benefits of cognition-behavior therapy.

IBRO NEUROSCIENCE REPORTS (2023)

Article Clinical Neurology

Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder

Maxwell Z. Price et al.

Summary: The objective of this study was to determine whether pediatric and adult ADHD patients would experience improvement in ADHD symptoms following voluntary, open-label switch to extended-release viloxazine. The study found that extended-release viloxazine had better improvement in inattention and hyperactivity/impulsivity compared to atomoxetine, with greater tolerability.

CNS DRUGS (2023)

Review Clinical Neurology

Pathology and Astrocytes in Autism

Gelareh Vakilzadeh et al.

Summary: The pathology of autism spectrum disorder (ASD) is not well understood, but recent studies suggest that glial cell pathology may be a characteristic of ASD. Astrocytes, the most abundant glial cells in the brain, play a crucial role in neuronal function during development and adulthood. Changes in astrocyte number and/or function may contribute to the connectivity impairment observed in ASD. Limited data suggests that the number of astrocytes is reduced while their activation state and expression of GFAP are increased in ASD. Dysfunctional astrocytes may impact neurotransmitter metabolism, synaptogenesis, and brain inflammation in ASD. Further research is needed to better understand the role of astrocytes in ASD.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2023)

Review Cell & Tissue Engineering

Cell Therapies for Autism Spectrum Disorder Based on New Pathophysiology: A Review

Makoto Nabetani et al.

Summary: Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder with increased prevalence worldwide. The relationship between ASD and neuroinflammation, microglia, and glucose metabolism has been extensively studied. Cell therapies have shown promising results in clinical studies for ASD treatment, suggesting a new paradigm for autism therapy.

CELL TRANSPLANTATION (2023)

Article Psychiatry

Torasemide Improves the Propionic Acid-Induced Autism in Rats: A Histopathological and Imaging Study

Murat Dogan et al.

Summary: The study aimed to assess the beneficial effects of torasemide, a Na+-K+-2Cl(-) cotransporter 1 inhibitor, on an experimental autism model induced by propionic acid. The results showed that the torasemide group scored higher on behavioral tests and had higher neuronal counts in the hippocampus and cerebellum. Additionally, levels of oxidative stress and inflammatory markers were lower in the torasemide group. Magnetic resonance spectroscopy also revealed a lower lactate value in the torasemide group. These findings suggest that torasemide may enhance gamma-aminobutyric acid activity and could be a potential treatment for autism with fewer side effects.

ALPHA PSYCHIATRY (2023)

Article Biochemistry & Molecular Biology

Guggulsterone Mediated JAK/STAT and PPAR-Gamma Modulation Prevents Neurobehavioral and Neurochemical Abnormalities in Propionic Acid-Induced Experimental Model of Autism

Rishabh Khera et al.

Summary: This study demonstrates the neuroprotective effects of Guggulsterone (GST) in an experimental model of autism induced by intracerebroventricular propionic acid (ICV PPA) in adult rats, suggesting its potential therapeutic use in autism spectrum disorder.

MOLECULES (2022)

Review Biochemistry & Molecular Biology

Environmental exposures associated with elevated risk for autism spectrum disorder may augment the burden of deleterious de novo mutations among probands

Kealan Pugsley et al.

Summary: The high heritability of autism spectrum disorder (ASD) suggests a predominant role of genetics in its development; environmental exposures may also play a causal role in the emergence of deleterious de novo variations; further research is needed to determine the direct contribution of these factors to the ASD phenotype.

MOLECULAR PSYCHIATRY (2022)

Review Neurosciences

Valproic Acid and Propionic Acid Modulated Mechanical Pathways Associated with Autism Spectrum Disorder at Prenatal and Neonatal Exposure

Amit Raj Sharma et al.

Summary: Autism spectrum disorder (ASD) is a neurodevelopmental disorder with both genetic and environmental factors playing a role in its etiology and pathophysiology. This article discusses the effects of environmental factors, such as valproic acid and propionic acid, on ASD development and the molecular pathways and genes involved.

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2022)

Article Plant Sciences

Jia Wei Xiao Yao San ameliorates chronic stress-induced depression-like behaviors in mice by regulating the gut microbiome and brain metabolome in relation to purine metabolism

Shuai Ji et al.

Summary: The study suggests that L. animalis is associated with depression-like behaviors in mice, and JWXYS increases the relative abundance of I. valens related to cerebral purine metabolism, which is positively correlated with the activation of astrocytes in the amygdala.

PHYTOMEDICINE (2022)

Article Endocrinology & Metabolism

PI3K/AKT/mTOR signalling inhibitor chrysophanol ameliorates neurobehavioural and neurochemical defects in propionic acid-induced experimental model of autism in adult rats

Aarti Sharma et al.

Summary: This study examined the neuroprotective effect of chrysophanic acid on an autism model induced by ICV-PPA in rats, and found that chrysophanic acid can reduce autism-like symptoms and restore abnormal neurochemical levels.

METABOLIC BRAIN DISEASE (2022)

Review Neurosciences

Role of RAGE in the Pathogenesis of Neurological Disorders

Judyta Juranek et al.

Summary: This review discusses the role of RAGE in the nervous system and highlights the incomplete understanding of this signaling pathway. While some clinical trials have not shown the expected therapeutic efficacy, there is still hope for treating nervous system diseases through the use of different blocking agents.

NEUROSCIENCE BULLETIN (2022)

Review Neurosciences

Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases

Kareem Khalaf et al.

Summary: Most neurodegenerative disorders are protein homeostasis diseases, and TUDCA has shown potential therapeutic use in these diseases by exerting anti-apoptotic and neuroprotective activities through various mechanisms.

TRANSLATIONAL NEURODEGENERATION (2022)

Editorial Material Cell Biology

A Wholistic View of How Bumetanide Attenuates Autism Spectrum Disorders

Eric Delpire et al.

Summary: Bumetanide, a specific NKCC1 cotransporter antagonist, shows potential in attenuating the severity of Autism Spectrum Disorders (ASD) and other neurodevelopmental or neurodegenerative disorders. However, its therapeutic efficacy may be challenged by the widespread expression of NKCC1 in various cell types. Additionally, disruptions in peripheral functions are linked to neurological sequels and increased incidence of the disorder. Therefore, a holistic approach considering both central and peripheral impacts may be beneficial in treating these disorders.

CELLS (2022)

Review Neurosciences

Neuroinflammation in autism spectrum disorders: potential target for mesenchymal stem cell-based therapy

Rebecca S. Y. Wong

Summary: This article provides an overview of the etiology and clinical aspects of Autism Spectrum Disorders (ASD), discusses the role of neuroinflammation in ASD, and explores the therapeutic effects of MSCs in ASD.

EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY (2022)

Article Neurosciences

The landscape of somatic mutation in cerebral cortex of autistic and neurotypical individuals revealed by ultra-deep whole-genome sequencing

Rachel E. Rodin et al.

Summary: Through characterizing genome-wide somatic mutations in autistic and control brains, this study reveals that unaffected individuals may also possess brain somatic mutations, shedding light on the role of somatic mutations in autism. The analysis shows that there are a certain number of somatic single-nucleotide variants present in each brain cell, which may affect coding and regulatory regions.

NATURE NEUROSCIENCE (2021)

Article Multidisciplinary Sciences

Blood biomarker discovery for autism spectrum disorder: A proteomic analysis

Laura Hewitson et al.

Summary: Current research efforts are focused on identifying potential blood biomarkers for autism spectrum disorder (ASD) to determine risk or aid in diagnosis. Proteomic analysis revealed altered levels of certain proteins in the serum of ASD boys, suggesting the possibility of using a panel of proteins as a blood biomarker. Further investigation is needed to validate the protein biomarker panel for ASD in boys.

PLOS ONE (2021)

Review Psychiatry

Systematic Review and Bioinformatic Analysis of microRNA Expression in Autism Spectrum Disorder Identifies Pathways Associated With Cancer, Metabolism, Cell Signaling, and Cell Adhesion

Zhi-Xiong Huang et al.

Summary: A systematic review identified multiple differentially expressed miRNAs in ASD, which are associated with autism risk genes and involved in various pathways related to ASD.

FRONTIERS IN PSYCHIATRY (2021)

Review Neurosciences

Metabolic Regulation of Glial Phenotypes: Implications in Neuron-Glia Interactions and Neurological Disorders

Ruqayya Afridi et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2020)

Article Behavioral Sciences

Day-to-Day Test-Retest Reliability of EEG Profiles in Children With Autism Spectrum Disorder and Typical Development

April R. Levin et al.

FRONTIERS IN INTEGRATIVE NEUROSCIENCE (2020)

Review Pharmacology & Pharmacy

Nuclear Factor Kappa B in Autism Spectrum Disorder: A Systematic Review

Xiaoli Liao et al.

PHARMACOLOGICAL RESEARCH (2020)

Article Cell & Tissue Engineering

Infusion of human umbilical cord tissue mesenchymal stromal cells in children with autism spectrum disorder

Jessica M. Sun et al.

STEM CELLS TRANSLATIONAL MEDICINE (2020)

Article Pharmacology & Pharmacy

Purinergic signaling orchestrating neuron-glia communication

Paula Agostinho et al.

PHARMACOLOGICAL RESEARCH (2020)

Article Immunology

Gut microbiota composition is associated with temperament traits in infants

Anna-Katariina Aatsinki et al.

BRAIN BEHAVIOR AND IMMUNITY (2019)

Review Neurosciences

Genetic Causes and Modifiers of Autism Spectrum Disorder

Lauren Rylaarsdam et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2019)

Review Biotechnology & Applied Microbiology

Genetics and epigenetics of autism spectrum disordercurrent evidence in the field

Barbara Wisniowiecka-Kowalnik et al.

JOURNAL OF APPLIED GENETICS (2019)

Article Medicine, General & Internal

Biomarkers for Autism Spectrum Disorders (ASD): A Meta-analysis

Ashley Ansel et al.

RAMBAM MAIMONIDES MEDICAL JOURNAL (2019)

Article Biochemistry & Molecular Biology

Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defects

H-J Kim et al.

MOLECULAR PSYCHIATRY (2017)

Article Multidisciplinary Sciences

The PDK1 Inhibitor Dichloroacetate Controls Cholesterol Homeostasis Through the ERK5/MEF2 Pathway

Abrar Ul Haq Khan et al.

SCIENTIFIC REPORTS (2017)

Article Neurosciences

mTOR, a Potential Target to Treat Autism Spectrum Disorder

Atsushi Sato

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2016)

Article Medicine, Research & Experimental

Therapeutic properties of mesenchymal stem cells for autism spectrum disorders

Benjamin Gesundheit et al.

MEDICAL HYPOTHESES (2015)

Article Neurosciences

A FreeSurfer view of the cortical transcriptome generated from the Allen Human Brain Atlas

Leon French et al.

FRONTIERS IN NEUROSCIENCE (2015)

Article Clinical Neurology

Longitudinal changes in cortical thickness in autism and typical development

Brandon A. Zielinski et al.

BRAIN (2014)

Article Genetics & Heredity

Serum microRNA profiles in children with autism

Mahesh Mundalil Vasu et al.

MOLECULAR AUTISM (2014)

Review Immunology

Immunological and autoimmune considerations of Autism Spectrum Disorders

Benjamin Gesundheit et al.

JOURNAL OF AUTOIMMUNITY (2013)

Article Psychiatry

Microglial Activation in Young Adults With Autism Spectrum Disorder

Katsuaki Suzuki et al.

JAMA PSYCHIATRY (2013)

Article Multidisciplinary Sciences

An anatomically comprehensive atlas of the adult human brain transcriptome

Michael J. Hawrylycz et al.

NATURE (2012)

Article Psychology, Developmental

Behavioral Correlates of Maternal Antibody Status Among Children with Autism

Daniel Braunschweig et al.

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2012)

Article Psychiatry

Early Brain Overgrowth in Autism Associated With an Increase in Cortical Surface Area Before Age 2 Years

Heather Cody Hazlett et al.

ARCHIVES OF GENERAL PSYCHIATRY (2011)

Article Cell Biology

NF-kappa B Signaling in the Brain of Autistic Subjects

Mazhar Malik et al.

MEDIATORS OF INFLAMMATION (2011)

Article Biochemistry & Molecular Biology

A genome-wide scan for common alleles affecting risk for autism

Richard Anney et al.

HUMAN MOLECULAR GENETICS (2010)

Article Immunology

Elevated immune response in the brain of autistic patients

Xiaohong Li et al.

JOURNAL OF NEUROIMMUNOLOGY (2009)

Article Genetics & Heredity

Heterogeneous dysregulation of microRNAs across the autism spectrum

Kawther Abu-Elneel et al.

NEUROGENETICS (2008)

Article Endocrinology & Metabolism

Effect of fatty acids and antioxidants on glucose tolerance

F. Stancioiu

ACTA ENDOCRINOLOGICA-BUCHAREST (2007)

Article Immunology

Elevated cytokine levels in children with autism spectrum disorder

CA Molloy et al.

JOURNAL OF NEUROIMMUNOLOGY (2006)

Article Clinical Neurology

Neuroglial activation and neuroinflammation in the brain of patients with autism

DL Vargas et al.

ANNALS OF NEUROLOGY (2005)

Article Cell Biology

Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjects

M Araghi-Niknam et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2003)